Psych Capital Plc is a publicly listed incubation and pre-seed investment firm that deploys early stage capital while usually operating or supporting emerging companies in the UK’s and Europe’s psychedelic science and healthcare industry.
We are not your average investment fund and we do a lot more than simply provide capital. We work with you to create the building blocks of an emerging industry.
We own the industry’s preeminent data, insights and networking platform, have considerable domain expertise as both investors and entrepreneurs, and are determined to nurture an industry based on science, not hype.
Our overarching mission is to identify the real opportunities in the market, and to find and incubate the most promising leaders to develop those areas through innovation and IP. We have the network and expertise to accelerate the growth of our portfolio companies while building sustainable value for our shareholder base.
Our focus is on identifying, funding and building category leaders across what we consider to be The industry’s three core pillars:
Our overarching mission is to leverage our network and expertise to accelerate the growth of our portfolio companies while building sustainable value for our shareholder base.
Assumes an active position in our portfolio partners, sharing access to our network of industry experts, scientific researchers and data analysts.
Relies on our board, advisor and network expertise, all composed of the some of the industry’s leading stakeholders.
Allocates and injects capital to operators where we can also add significant strategic and operational input.